Media Centre
Full-Year 2018 Results
AstraZeneca announced its Full-Year 2018 Results on Thursday 14 February 2019.
Go to Full-Year 2018 Results announcementLatest press releases
-
First sub-analyses from the DECLARE-TIMI 58 trial further support the cardiovascular effects of Farxiga in type-2 diabetes
-
US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis
-
AstraZeneca showcases next-generation Oncology pipeline addressing unmet patient needs at AACR Annual Meeting
-
AstraZeneca to present new cardiovascular data on Farxiga in type-2 diabetes at ACC 2019
-
Lynparza receives positive EU CHMP opinion for use in germline BRCA-mutated HER2-negative advanced breast cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Gonzalo Viña
Head of Global Media Relations
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
Jennifer Hursit
Manager Global Media Relations
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
